June 10, 2024 – The Abbott AVEIR™ Wi-fi Twin Chamber Pacemaker (DR) System is the world's first wi-fi twin chamber pacemaker to deal with individuals with irregular or gradual coronary heart rhythms. About 49 million individuals within the European Union undergo from heart problems, and based on Abbott, an estimated 14.4 million individuals aged 65 and over can have atrial fibrillation by 2060. AVEIR DR is a breakthrough innovation that allows the world's first beat-to-beat, wi-fi communication between two leadless pacemakers, designed to satisfy the wants of individuals with irregular coronary heart rhythms and broaden remedy choices.

The AVEIR DR i2i International Medical Investigation examine discovered that AVEIR DR met three pre-specified major endpoints for security and efficacy. The outcomes for 3 months after implantation confirmed a system implant success fee of 98.3% and greater than 97% of individuals had profitable atrioventricular synchronization in order that the higher and decrease chambers beat usually regardless of completely different positions and gaits.

The AVEIR DR leadless pacemaker system obtained US FDA approval in June 2023.

Study extra

Abbott press launch